ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	40.57	-18.52	18.78	-47.9	-42.6	-22.55
Depreciation & Amortization	91.4	67.73	59.79	59.65	47.25	44.64
Loss (Gain) From Sale of Assets	0.3	-5.35	-	-0.75	-1.82	-
Asset Writedown & Restructuring Costs	8.37	7.6	-	1.73	2.37	4.2
Loss (Gain) From Sale of Investments	-0.56	-6.31	-	-	-	-
Stock-Based Compensation	35.22	29.34	20.65	14.6	10.49	12.94
Other Operating Activities	-19.53	0.7	-5.12	-7.23	-12.28	-11.33
Change in Accounts Receivable	-56.19	-21.09	3.36	-36.91	-5.55	-23.66
Change in Inventory	-10.37	-21.29	-5.84	-23.63	3.22	-2.76
Change in Accounts Payable	15.57	0.48	7.55	5.04	10.17	-2.29
Change in Income Taxes	-3.15	-1.42	11.99	-0.16	-7.57	4.98
Change in Other Net Operating Assets	69.08	32.13	7.8	4.36	-0.35	11.11
Operating Cash Flow	170.72	64.02	118.96	-31.2	3.32	15.27
Operating Cash Flow Growth	83.77%	-46.19%	-	-	-78.24%	-66.54%
Capital Expenditures	-14.99	-16.24	-8.87	-8.88	-2.56	-6.14
Sale of Property, Plant & Equipment	-	13.51	-	0.75	2.65	-
Cash Acquisitions	-8.2	-401.28	-	-0.03	-84.49	-
Sale (Purchase) of Intangibles	-20.41	-0.72	-9.64	-7.58	-21.08	-62.19
Investing Cash Flow	-43.6	-404.72	-18.51	-15.74	-105.48	-68.32
Long-Term Debt Issued	-	641.25	-	-	310.03	15
Long-Term Debt Repaid	-	-296.03	-3	-3	-211.01	-15.53
Total Debt Repaid	-6.25	-296.03	-3	-3	-211.01	-15.53
Net Debt Issued (Repaid)	-6.25	345.22	-3	-3	99.02	-0.53
Issuance of Common Stock	15.27	6.49	89.55	1.46	71.65	0.62
Repurchase of Common Stock	-11.92	-10.96	-4.99	-1.96	-0.89	-1.52
Preferred Dividends Paid	-1.56	-1.63	-1.63	-1.63	-0.19	-
Dividends Paid	-1.56	-1.63	-1.63	-1.63	-0.19	-
Other Financing Activities	-5.75	-74.18	-12.5	-	-	-
Financing Cash Flow	-10.22	264.95	67.44	-5.13	194.6	-1.44
Foreign Exchange Rate Adjustments	0.73	-0.47	-	-	-	-
Net Cash Flow	117.63	-76.23	167.89	-52.07	92.43	-54.49
Free Cash Flow	155.73	47.78	110.09	-40.08	0.77	9.13
Free Cash Flow Growth	102.84%	-56.60%	-	-	-91.62%	-76.58%
Free Cash Flow Margin	18.83%	7.78%	22.61%	-12.67%	0.35%	4.38%
Free Cash Flow Per Share	7.58	2.47	6.05	-2.46	0.06	0.76
Cash Interest Paid	27.47	24.38	31.43	21.48	9.71	6.93
Cash Income Tax Paid	18.46	19.06	1.23	0.29	10.37	4.98
Levered Free Cash Flow	117.81	28.57	114.36	-38.7	-28.62	-49.91
Unlevered Free Cash Flow	138.38	49.28	136.26	-20.94	-21.16	-43.99
Change in Working Capital	14.95	-11.19	24.86	-51.3	-0.08	-12.63

Updated Nov 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q